FIELD: medicine, immunology. SUBSTANCE: invention relates to use of lexilium as phagocytosis-stimulating agent. Method provides enhancement of nonspecific resistance, in part, phagocytic activity of neutrophiles. EFFECT: decreased period of therapy, decreased severity of clinical symptomatics. 1 tbl
Authors
Dates
2001-01-27—Published
1999-11-12—Filed